This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mylin, L. M.
Right arrow Articles by Tevethia, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mylin, L. M.
Right arrow Articles by Tevethia, S. S.

 Previous Article  |  Next Article 

Journal of Virology, August 2000, p. 6922-6934, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Quantitation of CD8+ T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T-Antigen-Transformed Cells, or Vaccinia Virus Recombinants Expressing Full-Length T Antigen or Epitope Minigenes

Lawrence M. Mylin,1,dagger Todd D. Schell,1 Debra Roberts,1 Melanie Epler,1 Alina Boesteanu,1,Dagger Edward J. Collins,2,3 Jeffrey A. Frelinger,2 Sebastian Joyce,1,§ and Satvir S. Tevethia1,*

Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033,1 and Department of Microbiology and Immunology2 and Department of Biochemistry and Biophysics,3 School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599

Received 1 March 2000/Accepted 3 May 2000

The cytotoxic T-lymphocyte response to wild-type simian virus 40 large tumor antigen (Tag) in C57BL/6 (H2b) mice is directed against three H2-Db-restricted epitopes, I, II/III, and V, and one H2-Kb-restricted epitope, IV. Epitopes I, II/III, and IV are immunodominant, while epitope V is immunorecessive. We investigated whether this hierarchical response was established in vivo or was due to differential expansion in vitro by using direct enumeration of CD8+ T lymphocytes with Tag epitope/major histocompatibility complex class I tetramers and intracellular gamma interferon staining. The results demonstrate that epitope IV-specific CD8+ T cells dominated the Tag-specific response in vivo following immunization with full-length Tag while CD8+ T cells specific for epitopes I and II/III were detected at less than one-third of this level. The immunorecessive nature of epitope V was apparent in vivo, since epitope V-specific CD8+ T cells were undetectable following immunization with full-length Tag. In contrast, high levels of epitope V-specific CD8+ T lymphocytes were recruited in vivo following immunization and boosting with a Tag variant in which epitopes I, II/III, and IV had been inactivated. In addition, analysis of the T-cell receptor beta  (TCRbeta ) repertoire of Tag epitope-specific CD8+ cells revealed that multiple TCRbeta variable regions were utilized for each epitope except Tag epitope II/III, which was limited to TCRbeta 10 usage. These results indicate that the hierarchy of Tag epitope-specific CD8+ T-cell responses is established in vivo.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, H107, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033. Phone: (717) 531-8872. Fax: (717) 531-5578. E-mail: sst1{at}psu.edu.

dagger Present address: Messiah College, Grantham, PA 17027.

Dagger Present address: Wistar Institute, Philadelphia, PA 19104.

§ Present address: Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.


Journal of Virology, August 2000, p. 6922-6934, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Grebe, K. M., Hickman, H. D., Irvine, K. R., Takeda, K., Bennink, J. R., Yewdell, J. W. (2009). Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 106: 5300-5305 [Abstract] [Full Text]  
  • Tatum, A. M., Mylin, L. M., Bender, S. J., Fischer, M. A., Vigliotti, B. A., Tevethia, M. J., Tevethia, S. S., Schell, T. D. (2008). CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors. J. Immunol. 181: 4406-4417 [Abstract] [Full Text]  
  • Willimsky, G., Czeh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H., Blankenstein, T. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. JEM 205: 1687-1700 [Abstract] [Full Text]  
  • Goldberger, O., Volovitz, I., Machlenkin, A., Vadai, E., Tzehoval, E., Eisenbach, L. (2008). Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape. Cancer Res. 68: 3450-3457 [Abstract] [Full Text]  
  • Degl'Innocenti, E., Grioni, M., Capuano, G., Jachetti, E., Freschi, M., Bertilaccio, M. T.S., Hess-Michelini, R., Doglioni, C., Bellone, M. (2008). Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD4+CD25+ Regulatory T Cells. Cancer Res. 68: 292-300 [Abstract] [Full Text]  
  • Otahal, P., Knowles, B. B., Tevethia, S. S., Schell, T. D. (2007). Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors. J. Immunol. 179: 6686-6695 [Abstract] [Full Text]  
  • Otahal, P., Schell, T. D., Hutchinson, S. C., Knowles, B. B., Tevethia, S. S. (2006). Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice.. J. Immunol. 177: 3089-3099 [Abstract] [Full Text]  
  • Ryan, C. M., Schell, T. D. (2006). Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope. J. Immunol. 177: 255-267 [Abstract] [Full Text]  
  • York, I. A., Brehm, M. A., Zendzian, S., Towne, C. F., Rock, K. L. (2006). Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103: 9202-9207 [Abstract] [Full Text]  
  • Velupillai, P., Garcea, R. L., Benjamin, T. L. (2006). Polyoma Virus-Like Particles Elicit Polarized Cytokine Responses in APCs from Tumor-Susceptible and -Resistant Mice. J. Immunol. 176: 1148-1153 [Abstract] [Full Text]  
  • Otahal, P., Hutchinson, S. C., Mylin, L. M., Tevethia, M. J., Tevethia, S. S., Schell, T. D. (2005). Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope. J. Immunol. 175: 700-712 [Abstract] [Full Text]  
  • Casati, A., Zimmermann, V. S., Benigni, F., Bertilaccio, M. T. S., Bellone, M., Mondino, A. (2005). The Immunogenicity of Dendritic Cell-Based Vaccines Is Not Hampered by Doxorubicin and Melphalan Administration. J. Immunol. 174: 3317-3325 [Abstract] [Full Text]  
  • Haeryfar, S. M. M., DiPaolo, R. J., Tscharke, D. C., Bennink, J. R., Yewdell, J. W. (2005). Regulatory T Cells Suppress CD8+ T Cell Responses Induced by Direct Priming and Cross-Priming and Moderate Immunodominance Disparities. J. Immunol. 174: 3344-3351 [Abstract] [Full Text]  
  • Kim, S.-K., Cornberg, M., Wang, X. Z., Chen, H. D., Selin, L. K., Welsh, R. M. (2005). Private specificities of CD8 T cell responses control patterns of heterologous immunity. JEM 201: 523-533 [Abstract] [Full Text]  
  • Bartholdy, C., Stryhn, A., Christensen, J. P., Thomsen, A. R. (2004). Single-Epitope DNA Vaccination Prevents Exhaustion and Facilitates a Broad Antiviral CD8+ T Cell Response during Chronic Viral Infection. J. Immunol. 173: 6284-6293 [Abstract] [Full Text]  
  • Belnoue, E., Guettier, C., Kayibanda, M., Le Rond, S., Crain-Denoyelle, A.-M., Marchiol, C., Ziol, M., Fradelizi, D., Renia, L., Viguier, M. (2004). Regression of Established Liver Tumor Induced by Monoepitopic Peptide-Based Immunotherapy. J. Immunol. 173: 4882-4888 [Abstract] [Full Text]  
  • Wang, X. Z., Brehm, M. A., Welsh, R. M. (2004). Preapoptotic Phenotype of Viral Epitope-Specific CD8 T Cells Precludes Memory Development and Is an Intrinsic Property of the Epitope. J. Immunol. 173: 5138-5147 [Abstract] [Full Text]  
  • Yoshimura, Y., Yadav, R., Christianson, G. J., Ajayi, W. U., Roopenian, D. C., Joyce, S. (2004). Duration of Alloantigen Presentation and Avidity of T Cell Antigen Recognition Correlate with Immunodominance of CTL Response to Minor Histocompatibility Antigens. J. Immunol. 172: 6666-6674 [Abstract] [Full Text]  
  • Barton, L. F., Runnels, H. A., Schell, T. D., Cho, Y., Gibbons, R., Tevethia, S. S., Deepe, G. S. Jr., Monaco, J. J. (2004). Immune Defects in 28-kDa Proteasome Activator {gamma}-Deficient Mice. J. Immunol. 172: 3948-3954 [Abstract] [Full Text]  
  • Kim, S.-K., Welsh, R. M. (2004). Comprehensive Early and Lasting Loss of Memory CD8 T Cells and Functional Memory during Acute and Persistent Viral Infections. J. Immunol. 172: 3139-3150 [Abstract] [Full Text]  
  • Schell, T. D. (2004). In Vivo Expansion of the Residual Tumor Antigen-Specific CD8+ T Lymphocytes That Survive Negative Selection in Simian Virus 40 T-Antigen-Transgenic Mice. J. Virol. 78: 1751-1762 [Abstract] [Full Text]  
  • Schirmbeck, R., Riedl, P., Zurbriggen, R., Akira, S., Reimann, J. (2003). Antigenic Epitopes Fused to Cationic Peptide Bound to Oligonucleotides Facilitate Toll-Like Receptor 9-Dependent, but CD4+ T Cell Help-Independent, Priming of CD8+ T Cells. J. Immunol. 171: 5198-5207 [Abstract] [Full Text]  
  • Stanic, A. K., Shashidharamurthy, R., Bezbradica, J. S., Matsuki, N., Yoshimura, Y., Miyake, S., Choi, E. Y., Schell, T. D., Van Kaer, L., Tevethia, S. S., Roopenian, D. C., Yamamura, T., Joyce, S. (2003). Another View of T Cell Antigen Recognition: Cooperative Engagement of Glycolipid Antigens by Va14Ja18 Natural TCR. J. Immunol. 171: 4539-4551 [Abstract] [Full Text]  
  • Staveley-O'Carroll, K., Schell, T. D., Jimenez, M., Mylin, L. M., Tevethia, M. J., Schoenberger, S. P., Tevethia, S. S. (2003). In Vivo Ligation of CD40 Enhances Priming Against the Endogenous Tumor Antigen and Promotes CD8+ T Cell Effector Function in SV40 T Antigen Transgenic Mice. J. Immunol. 171: 697-707 [Abstract] [Full Text]  
  • Yadav, R., Yoshimura, Y., Boesteanu, A., Christianson, G. J., Ajayi, W. U., Shashidharamurthy, R., Stanic, A. K., Roopenian, D. C., Joyce, S. (2003). The H4b Minor Histocompatibility Antigen Is Caused by a Combination of Genetically Determined and Posttranslational Modifications. J. Immunol. 170: 5133-5142 [Abstract] [Full Text]  
  • Brehm, M. A., Markees, T. G., Daniels, K. A., Greiner, D. L., Rossini, A. A., Welsh, R. M. (2003). Direct Visualization of Cross-Reactive Effector and Memory Allo-Specific CD8 T Cells Generated in Response to Viral Infections. J. Immunol. 170: 4077-4086 [Abstract] [Full Text]  
  • Rodriguez, F., Harkins, S., Slifka, M. K., Whitton, J. L. (2002). Immunodominance in Virus-Induced CD8+ T-Cell Responses Is Dramatically Modified by DNA Immunization and Is Regulated by Gamma Interferon. J. Virol. 76: 4251-4259 [Abstract] [Full Text]  
  • Kumaraguru, U., Gierynska, M., Norman, S., Bruce, B. D., Rouse, B. T. (2002). Immunization with Chaperone-Peptide Complex Induces Low-Avidity Cytotoxic T Lymphocytes Providing Transient Protection against Herpes Simplex Virus Infection. J. Virol. 76: 136-141 [Abstract] [Full Text]  
  • Schell, T. D., Tevethia, S. S. (2001). Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of Donor CD8+ T Lymphocytes by the Endogenous Tumor Antigen. J. Immunol. 167: 6947-6956 [Abstract] [Full Text]  
  • Eo, S. K., Kumaraguru, U., Rouse, B. T. (2001). Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells. J. Immunol. 167: 3592-3599 [Abstract] [Full Text]  
  • Serreze, D. V., Johnson, E. A., Chapman, H. D., Graser, R. T., Marron, M. P., DiLorenzo, T. P., Silveira, P., Yoshimura, Y., Nathenson, S. G., Joyce, S. (2001). Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand From a Greatly Reduced Precursor Pool. Diabetes 50: 1992-2000 [Abstract] [Full Text]  
  • Choi, E. Y., Yoshimura, Y., Christianson, G. J., Sproule, T. J., Malarkannan, S., Shastri, N., Joyce, S., Roopenian, D. C. (2001). Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others. J. Immunol. 166: 4370-4379 [Abstract] [Full Text]  
  • Schell, T. D., Lippolis, J. D., Tevethia, S. S. (2001). Cytotoxic T Lymphocytes from HLA-A2.1 Transgenic Mice Define a Potential Human Epitope from Simian Virus 40 Large T Antigen. Cancer Res. 61: 873-879 [Abstract] [Full Text]  
  • Kumaraguru, U., Davis, I. A., Deshpande, S., Tevethia, S. S., Rouse, B. T. (2001). Lymphotoxin {{alpha}}-/- Mice Develop Functionally Impaired CD8+ T Cell Responses and Fail to Contain Virus Infection of the Central Nervous System. J. Immunol. 166: 1066-1074 [Abstract] [Full Text]